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Walkability and its association with
prevalent and incident diabetes among
adults in different regions of Germany:
results of pooled data from five German
cohorts
Nadja Kartschmit1,2, Robynne Sutcliffe3, Mark Patrick Sheldon4, Susanne Moebus3, Karin Halina Greiser1,5,
Saskia Hartwig1,2, Detlef Thürkow6, Ulrike Stentzel7, Neeltje van den Berg7, Kathrin Wolf2,8, Werner Maier2,9,
Annette Peters2,8, Salman Ahmed3, Corinna Köhnke10, Rafael Mikolajczyk1, Andreas Wienke1,
Alexander Kluttig1,2* and Gavin Rudge4
Abstract
Background: Highly walkable neighbourhoods may increase transport-related and leisure-time physical activity and
thus decrease the risk for obesity and obesity-related diseases, such as type 2 diabetes (T2D).
Methods: We investigated the association between walkability and prevalent/incident T2D in a pooled sample
from five German cohorts. Three walkability measures were assigned to participant’s addresses: number of transit
stations, points of interest, and impedance (restrictions to walking due to absence of intersections and physical
barriers) within 640 m. We estimated associations between walkability and prevalent/incident T2D with modified
Poisson regressions and adjusted for education, sex, age at baseline, and cohort.
Results: Of the baseline 16,008 participants, 1256 participants had prevalent T2D. Participants free from T2D at
baseline were followed over a mean of 9.2 years (SD: 3.5, minimum: 1.6, maximum: 14.8 years). Of these, 1032
participants developed T2D. The three walkability measures were not associated with T2D. The estimates pointed
toward a zero effect or were within 7% relative risk increase per 1 standard deviation with 95% confidence intervals
including 1.
Conclusion: In the studied German settings, walkability differences might not explain differences in T2D.
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Background
Unhealthy diet and physical inactivity are important risk
factors for developing non-communicable diseases, such
as type 2 diabetes (T2D) [1]. While the prevention of
such diseases is still focused on individual health behav-
iours, there is currently an increasing interest in setting-
based prevention initiatives [2–4]. There is evidence that
improved neighbourhood walkability, as characteristic of
the built environment, increases walking and cycling.
Hence, walkability may be associated with a reduced risk
of obesity and T2D via increased transport-related and
leisure-time physical activity [5–12].
Existing research showing a positive relationship be-
tween higher walkability and lower risk of incident and
prevalent T2D comes mainly from Australia and North
America [12, 13]. Since the built environment in Europe
differs from Australia and North America [14, 15], it is
not clear whether this association also exists in European
countries. However, so far, there is only one study from
Sweden showing no effect of walkability on incident T2D
[16]. Our previous pooled analysis of data from five
German cohorts indicated a weak association between
higher walkability and lower body mass index (BMI) [17].
Most previous studies categorized continuous walk-
ability measures, which is problematic in terms of loss of
power and difficulties in pooling estimates from different
studies [18]. Furthermore, most studies used a walkability
score and did not assess walkability measures separately. A
score does not permit conclusions as to which walkability
parameter contributes most to the association with T2D
and hampers comparability between studies since many
options exist on which parameters to include in an index
and how to weight them [19, 20].
In the current study, we assessed the association be-
tween three walkability measures and T2D prevalence
and incidence in the German population using data from
five German cohort studies.
Methods
Study population
Data from five population-based cohort studies from dif-
ferent German areas were included: The Heinz Nixdorf
Recall Study (HNR), the Dortmund Health Study (DHS),
both conducted in Western Germany, the Cooperative
Health Research in the Region of Augsburg (KORA) S4
Survey from the South of Germany, The Cardiovascular
Disease Living and Ageing in the city of Halle (CARLA)
Study, and the Study of Health in Pomerania (SHIP), the
latter two from the Eastern area of Germany. A detailed
description of the studies can be found elsewhere [21–27].
Baseline data of all studies were collected between 1997
and 2006. Baseline response ranged from 56 to 69%.
Except for the DHS cohort with only one follow-up exam-
ination, all other cohort studies conducted at least two
follow-up examinations. The follow-up investigations took
place between 2002 and 2016 with mean observation
times ranging from 2.2 years to 13.6 years. Participation at
follow-ups ranged between 53.5 and 76.6% (of all baseline
participants).
The studies have been conducted according to the
principles of the Declaration of Helsinki and have been
approved by local ethics committees and written in-
formed consent has been obtained.
In total, 17,453 participants were included in the
pooled sample of the five cohort studies. Cross-sectional
data from 16,008 and longitudinal data from 12,105
participants were available for analysing the association
between the walkability measures and prevalent and in-
cident T2D, respectively, after excluding participants
with missing values for exposure, outcome, or covariates
(Fig. 1).
Fig. 1 Study population for prevalent and incident diabetes analysis
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Walkability measures
For deriving the walkability measures, the ArcGIS
Geoinformation System in ESRI ArcMap Desktop ver-
sions 10.1 and 10.4 was used [Environmental Systems
Research Institute (ESRI) 2012. 10.4, A.D.A.(ed.). Red-
lands]. We created a hexagonal sampling grid across
each of the study regions covering the municipal bound-
ary from which cohort participants had been recruited
and a buffer of 1 kilometre beyond. Spatial interpolation
will produce some spurious values at the edges of the
areas it is applied to, so where possible it is performed on
a larger area than needed and the resulting surface is
trimmed to the extent of the study area. We picked 1000
m as the side length for the hexagons. The size of the
hexagons was chosen pragmatically. We calculated hex-
agonal polygons depicting the area within a walking dis-
tance of 640m for each of the hexagon’s vertices and
centroids by using paths, walkways, and roads (Fig. 2).
The transport networks (here transit stations) and
points of interest (POI) for the cities were provided by
OpenSteetMap (OSM) in 2016 and processed using
ArcGIS to create the network dataset.
The three walkability measures derived were the
following:
POI: For each vertice and centroid of the hexagons we
calculated a polygon representing the area that could be
reached within a walking distance of 640 m, using roads,
walkways and paths on the OSM network. There is
very little research on what constitutes a short walk.
The cut-off of 640 m was chosen because research
carried out in London had proposed that the propen-
sity to walk to access public transport declined rap-
idly after 640 m [28]. We took this a pragmatic
definition of a short, accessible walking distance. We
defined POI using OSM. These POI were geo-located
and subsequently given a descriptive tag and allocated
to a category. For example, an entry may be tagged
as ‘bookshop’ in the category ‘shop’, a cash dispenser
may be tagged ‘ATM’ in the category ‘amenity’. In
each polygon we captured the number of points clas-
sified as a shop. In addition, we also selected some
points classified as ‘amenity’ by undertaking a thor-
ough review of the used tags. For each polygon, we
thus summed up all shops and amenities tagged:
ATM, bank, bar, Biergarten, café, fast food restaurant,
pharmacy, pub, restaurant, and post office.
Transit stations: We followed exactly the same method
to determine transit point availability as we did for POI.
In the category ‘highway’ we captured all of the points
tagged as ‘bus stop’. In the category ‘railway’ we captured
all points tagged as ‘stop’, ‘tram stop’, ‘station’, ‘subway
entrance’ ‘entrance’ or ‘platform’ and in the category
‘amenity’ we captured all the points tagged as ‘bus
station’, and ‘ferry terminal’.
Fig. 2 Walk polygons with hexagon centroids and vertrices. The figure shows one area of Essen city (Heinz Nixdorf Recall study area). For creating
the map, OpenStreetMap data was used. OpenStreetMap® is open data, licensed under the Open Data Commons Open Database License by the
OpenStreetMap Foundation. Note to the journal: please use colours for print
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Impedance: Typically, connectivity is used as a proxy
measure for impedance. Highly connected roads and
paths will have many network notes (junctions of roads
for example). Usually, the number of nodes of a road
and path network in a given radius is counted to derive
a simple metric of impedance. However, this approach
does not capture physical barriers. Hence, we used an
approach that would not only capture lack of intersec-
tions, but also physical barriers. From the centroid of
each hexagon we calculated six journeys in six different
directions: Northeast, Northwest, West, Southwest,
Southeast, and East from the centre to each vertex of
the hexagon. The six values vary according to ease of
access in the various directions with higher values
reflecting a lack of ease of walking in that direction. For
example, if a point, which was 1000m Euclidian distance
away, was accessible by a journey of 2300m this was 2.3
times larger than the Euclidian distance. A comparable
1000 m Euclidian distance that can be walked in 1050m
clearly has fewer barriers.
Each of the metrics was interpolated between the
points to construct a surface. We used Kriging to
interpolate values between the hexagonal points. Kriging
estimates values between points of known values on a
plane using a Gaussian regression process and is a
widely used method in spatial modelling.
We intersected all created surfaces with the baseline
residential addresses of the cohort’s participants. All
walkability surfaces were created in 2016.
For DHS, only information on baseline residential
addresses was available. Walkability measures could not
be computed for 3% at baseline, 16% at follow-up 1 and
3.6% at follow-up 2, because addresses could not be
geocoded.
Outcomes
Prevalent and incident T2D were defined by self-report
of physician-diagnosed diabetes or antidiabetic drug
intake in the 7 days prior to the examination.
Covariates
Number of years of education was derived from a stan-
dardized questionnaire. Years of education were classi-
fied based on the International Standard Classification of
Education 1997 [29], including school years and years of
vocational education in the total number of years with
the categories: 9/10 years, 12/13 years, 14–17 years and
18 and more years. Eleven years is not included, since in
Germany one can finish school after 9 or 10 years and
then start vocational education or unskilled working, or
one can finish after 12 or 13 years, which qualifies for
university entry. Baseline BMI was derived from mea-
sured weight and height using comparable protocols in
the five cohort studies. Self-reported hours per week of
practicing sports were categorized with the following
categories: more than 2 h, 1–2 h, less than 1 h of sports
per week and practicing no sports.
Statistical analysis
Sample characteristics were reported as means with
standard deviation (SD) or medians with interquartile
range (IQR) according to the distribution of the data or
as frequencies (percentages) for categorical variables.
For associations between walkability measures and
prevalent and incident T2D, we estimated risk ratios
(RR) using modified Poisson regression with robust error
variance [30, 31]. For better interpretability and compar-
ability, we present estimates for z-standardized walkability
measures.
In sensitivity analysis, we examined the association
between walkability measures and T2D incidence in a
sub-sample of participants whose addresses were the
same during each of the follow-up assessments (here-
after ‘non-movers’). Additionally, we examined the asso-
ciation between walkability measures and T2D incidence
in a sub-sample excluding all participants aged less than
30 years at baseline in order to exclude potential type 1
diabetes cases from the analysis. Finally, we also con-
ducted an analysis in which we used the T2D status at
the last follow-up as outcome in order to reduce the
time gap between walkability assessment and T2D
prevalence assessment.
We adjusted all models for sex, age at baseline, educa-
tion, and cohort. Additionally, we examined if the associa-
tions differed in certain age groups (20–40 years, 41–60
years and over 60 years). Moreover, we adjusted the asso-
ciations for practicing sports. All analyses were performed
with SAS V.9.4 [32].
Results
Of the baseline 16,008 participants, 1256 (7.8%) had
prevalent T2D. During the follow up over a mean of 9.2
years (SD: 3.5, minimum: 1.6, maximum: 14.8 years),
further 1032 participants developed T2D. Participants
with prevalent or incident T2D were more often male,
older, and had fewer years of education when compared
to participants without T2D. Additionally, participants
with T2D lived in areas with slightly more transit sta-
tions and POI when compared to participants without
T2D. Impedance at the participant’s residential addresses
was comparable in participants with and without T2D
(Table 1). All estimates for the association between the
walkability measures and T2D prevalence and incidence
were within 7% of RR = 1 per 1 SD, with 95% confidence
intervals including 1 (Table 2), showing no association
between walkability measures and T2D. Given the large
sample size, the 95% confidence intervals were narrow,
indicating high precision of our estimates.
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Table 1 Characteristics of participants
Sample for examining prevalent T2D
(N = 16,008)
Sample for examining incident T2D
(N = 12,105)
Prevalent T2D at baseline
(N = 1256)
No T2D at baseline
(N = 14,752)
Incident T2D during follow-up
(N = 1032)
No T2D during follow-up
(N = 11,073)
Male n (%) 707 (56.3) 7231 (49.0) 588 (57.0) 5271 (47.6)
Age at baseline Mean (SD) 63.9 (9.8) 53.5 (13.9) 59.0 (9.9) 52.9 (13.4)
Education (years)
9–10 n (%) 260 (20.7) 1598 (10.8) 112 (10.9) 1012 (9.1)
12–13 n (%) 613 (48.8) 7722 (52.3) 575 (55.7) 5731 (51.8)
14–17 n (%) 218 (17.4) 2786 (18.9) 189 (18.3) 2168 (19.6)
≥ 18 n (%) 165 (13.1) 2646 (17.9) 156 (15.1) 2162 (19.5)
Walkability measures
Impedance Mean (SD) 1623.9 (307.4) 1616.1 (289.9) 1615.3 (267.1) 1616.5 (288.6)
Transit stations Median (Q1-Q3) 4.6 (2.7–6.9) 4.3 (2.3–6.9) 4.7 (2.5–7.1) 4.3 (2.4–6.9)
Points of interest Median (Q1-Q3) 5.0 (2.3–10.1) 4.8 (2.1–9.5) 5.3 (2.6–9.8) 4.8 (2.2–9.0)
Risk factors for T2D
Practicing sports
More than 2 h/week n (%) 196 (15.7) 3470 (23.7) 200 (19.5) 2804 (25.5)
1–2 h/week n (%) 144 (11.5) 2767 (18.8) 156 (15.2) 2169 (19.7)
Less than 1 h/week n (%) 97 (7.7) 1673 (11.4) 111 (10.8) 1257 (11.4)
No sports n (%) 814 (65.1) 6758 (46.1) 560 (54.5) 4783 (43.4)
BMI at baseline Mean (SD), n 30.5 (5.3), 1252 27.3 (4.6), 14,684 30.6 (4.8), 1024 27.0 (4.4), 11,042
T2D Type 2 diabetes, SD Standard deviation, Q Quartile, BMI Body mass index
Table 2 Association between T2D and walkability
Sensitivity analysis
Prevalent T2D
(N = 16,008)
Incident T2D
(N = 12,105)
Incident T2D non-movers
(N = 5901)
Incident T2D age≥ 30 years at baseline
(N = 11,416)
RR 95% CI RR 95% CI RR 95% CI RR 95% CI
Impedance
Crude 1.02 0.97, 1.08 1.00 0.94, 1.05 0.99 0.92, 1.07 1.00 0.95, 1.07
Adjusted 1.03 0.97, 1.09 1.00 0.94, 1.06 1.02 0.95, 1.11 0.99 0.93, 1.06
Transit stations
Crude 1.05 0.99, 1.10 1.07 1.01, 1.13 1.09 1.00, 1.17 1.05 0.99, 1.11
Adjusted 1.03 0.97, 1.10 1.05 0.98, 1.13 1.05 0.97, 1.15 1.06 0.98, 1.14
Points of interest
Crude 1.04 0.99, 1.09 1.06 0.99, 1.12 1.02 0.95, 1.10 1.05 0.99, 1.11
Adjusted 1.05 0.99, 1.11 1.01 0.95, 1.08 0.98 0.91, 1.07 1.01 0.95, 1.08
Adjusted models are controlled for sex, age at baseline, education, and cohort. T2D Type 2 diabetes, RR Relative risk, CI Confidence interval. RR are from modified
Poisson regression models and reported per 1 standard deviation of walkability measures. RR over 1 indicate higher risk of T2D in areas with more transit stations
and POI (indicators of better walkability). RR over 1 indicate higher risk of T2D in areas with higher impedance (indicator of poorer walkability)
For prevalent T2D analysis (N = 16,008): standard deviation (SD) impedance: 291.3, POI: 4.8, transit stations: 4.4
For incident T2D analysis (N = 12,105): SD impedance: 286.8, POI: 7.1, transit stations: 5.3
For incident T2D non-movers (N = 5901) SD impedance = 284.6, POI: 6.7, transit stations: 4.9
For incident T2D age ≥ 30 years at baseline (N = 11,416) SD impedance: 282.5, POI: 7.5, transit stations: 4.1
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Results of a sensitivity analysis assessing the associ-
ation between walkability and the most recent follow-up
status on T2D were qualitatively the same (for imped-
ance RR 0.99; 95% CI 0.95, 1.04; POI: 1.02; 0.98, 1.06;
transit stations: 1.07; 1.01, 1.13, n = 9441).
These result of no association between walkability and
T2D was confirmed by further analysis, were we strati-
fied for age group and adjusted for practicing sports (See
Additional file 1: Table S1 and S2).
Discussion
In the present study we analysed data from 16,008 par-
ticipants from five German cohort studies. Our results
point towards a lack of association between walkability
and T2D in the studied environments.
Walkability was measured in different ways in different
studies, which hinders comparability of our results with
the current literature. However, most studies showed a
lower T2D risk with better walkability. Pooled effects in
a recent review would translate into a 20% T2D risk re-
duction with better walkability [12].
Most studies that found associations between better
walkability and decreased T2D risk used objective com-
posite scores including measures we did not take into
account, for example residential, population and inter-
section density, and land use mix [33–36]. While these
studies combined different walkability measures into an
index score and found association with diabetes, we
aimed to analyze the contribution of single measures.
Christine and colleagues (2015) found associations for
better subjective walkability measures, which we did not
consider, and decreased T2D risk [37]. We focused on
the classical and rather gross features of walkability that
arose from urban planning. We did not consider fine
features, such as bike path, pedestrian crossings, or ave-
nues, nor did we consider green spaces and parks. More-
over, we did not include aesthetics and perceived safety.
These walkability measures could be more important in
determining especially leisure time related walking than
single gross features of walkability [38]. Therefore, these
measures would also be more important regarding T2D
risks. Paquet et al. (2014) reported a 12% reduced risk
with increasing walkability in a smaller sample and less
years of follow-up when compared to our population
[39]. The study took place in Adelaide, South Australia,
which is different from European cities in terms of built
environment attributes [14, 39].
The density and diversity of European cities and their
city centres may have a greater potential to promote
physical activity for transport and leisure time as when
compared to Australia, where the structures of the cities
are more car-oriented and more heterogeneous regard-
ing walkability [38]. The homogeneity of the walkability
measures in our study regions could explain the
observed lack of association. Additionally, Paquet
et al. (2014) analysed diabetes and prediabetes as one
clinical endpoint, which hinders comparability with
our results [39].
However, not all studies have found associations be-
tween walkability and T2D. Müller-Riemenschneider
and colleagues (2013) reported that after adjustment for
individual SES, the previously existing positive effect of
walkability on incident T2D disappeared [40]. Neverthe-
less, the estimates still pointed towards a decreased T2D
risk with better walkability.
The only other study we know about that was con-
ducted in the European context found no association be-
tween walkability and diabetes in the city of Stockholm
[16]. This study only included participants who were
taking medication because of their disease. On the one
hand, the exclusion of participants with T2D not taking
medication could have underestimated the effect [41].
On the other hand, these results could also indicate the
homogeneity of walkability measures in European cities,
as indicated by our study.
Various specific factors could explain the null effect
for T2D with more POI and transit stations in our study.
First, POI included restaurants and fast food chains. Eat-
ing out of home is associated with obesity and could by
increasing the T2D risk, diminish any positive effect of
walkability [42]. Regarding transit stations, high cost of
public transport, low frequency routes and transport that
serves only few routes could hinder transport related
walking and promote car-dependence, even though pub-
lic transport is available. Consequently, this would result
in a null effect, as observed in our study. Additionally,
some environmental factors are associated with high ur-
banity and with high walkability. These factors, such as
air pollution, could at the same time increase the risk of
T2D and hence diminish the positive effect walkability
has on T2D, which would result in no observable effect
[43]. Regarding impedance, we did not observe any asso-
ciations with T2D. This may be due to different ways of
how impedance could work. People living in areas with
high impedance could be less likely to walk, which
would lead to lower activity and higher T2D risk. How-
ever, when it is inconvenient to use a car, activity could
increase and T2D risk would decrease. Areas which have
different road networks, parking availability and parking
cost could be different in the effect impedance has on
people’s walking and cycling behavior and hence on
their T2D risk. A river as a geographical barrier could
hinder transport related walking. At the same time, it
could increase leisure time related walking, jogging or
cycling for recreation.
In our recent cross-sectional analysis on a similar
pooled study population, better walkability was associ-
ated with lower BMI, but the observed associations were
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rather weak [17]. The already weak positive effect of
walkability via increased walking and cycling on BMI
may simply not be strong enough to have any observable
effects on T2D, which lies one step further down the
causal chain. Additionally, when we stratified the associ-
ations by cohort, we observed that the association
between better walkability and lower BMI was not con-
sistent among the cohorts. As described above, even
though walkability could contribute to increased walking
and cycling behaviour and therefor to decreased BMI
(even though to a very low extent), other factors related
to walkability could diminish possible positive effects of
walkability on health outcomes resulting from obesity
and hence, resulting in a lack of association.
Some limitations need to be considered. First, diabetes
was based on self-report. However, results of several
studies indicate that for diabetes the validity of self-
reports is generally high [44, 45]. Moreover, we could
not adjust for residential self-selection and only adjusted
for education as one part of individual SES, but not for
income, occupation, or area level SES.
Participants, who choose to live in a walkable area,
might be more health-conscious, have a higher income
and live a healthier lifestyle than people, who cannot
afford living in the city centre, where rents, but also con-
nectivity as well as the amount of transit stations and
POI might be higher. Hence, regardless of walking and
cycling for recreation and transport, those people would
have lower T2D risk than participants with low socio-
economic status, who are living in low walkable areas.
Although we adjusted for education in our analysis, edu-
cation alone does not reflect socioeconomic status, resi-
dential self-selection, and general health behaviour.
Income level and social status influence T2D risk and
walkability. However, we did not observe any association
between walkability and T2D risk in crude and adjusted
models and the adjustment for education only yielded
minor changes in the association when compared to the
crude association.
The strongest limitation is that the walkability mea-
sures were compiled for a much later time period then
baseline data, which could have resulted in misclassifica-
tion of walkability measures. However, we could show
that the analysis based on the last follow-up status of
T2D as outcome produced similar results. One can as-
sume that if there is some fluctuation in for example
points of interest over time, than still it occurs mostly
within the same areas, minimizing the risk of misclassifi-
cation. Furthermore, we did not include other important
aspects of walkability, such as perceived aesthetics,
safety, residential density, and presence of green spaces
and parks. Lastly, there are some limitations of our walk-
ability measures. Variety of POI was not explicitly taken
into account and bus and tram stops might be very
different in quality, according to high or low frequency
routes. While impedance indicates lack of walkable
streets, it can include rivers and forests which might be
on the other hand highly attractive for walking.
Despite these limitations, the study has several strengths.
Different regions and cities in Germany were taken into
account. With pooling data from five cohorts, we were able
to cover almost an entire European country. Most previous
studies included single cities in a country and were mostly
conducted in North America and Australia. This study is
one of the first studies that examined the association
between walkability and T2D in Europe.
Conclusion
Overall, the results of our study rather indicate a lack of
association between walkability and T2D risk in German
settings. This might be due to the homogeneity of the
walkability measures in the studied population.
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